N, I., T, S., Y, I., H, A., T, N., T, T., & S, N. (2021). A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis. Dove Medical Press.
Style de citation Chicago (17e éd.)N, Ishii, Shimizu T, Ishiura Y, Amuro H, Nishizawa T, Tamaki T, et Nomura S. A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis. Dove Medical Press, 2021.
Style de citation MLA (8e éd.)N, Ishii, et al. A Single-Center Retrospective Observational Study Evaluating the Favorable Predictive Factors for the Disease Control Time of Treatment with Tocilizumab in Patients of Rheumatoid Arthritis. Dove Medical Press, 2021.